NasdaqGM - Nasdaq Real Time Price USD
Exagen Inc. (XGN)
At close: November 15 at 4:00 PM EST
Pre-Market: 8:00 AM EST
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 3 | 4 | 4 |
| Avg. Estimate | -0.24 | -0.24 | -0.9 | -0.72 |
| Low Estimate | -0.3 | -0.27 | -0.93 | -0.82 |
| High Estimate | -0.1 | -0.2 | -0.86 | -0.56 |
| Year Ago EPS | -0.31 | -0.19 | -1.34 | -0.9 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 5 | 6 | 6 |
| Avg. Estimate | 13.53M | 14.66M | 55.53M | 65.15M |
| Low Estimate | 13.4M | 14M | 55.4M | 62.7M |
| High Estimate | 13.8M | 15M | 55.8M | 71.5M |
| Year Ago Sales | 13.77M | 14.41M | 52.55M | 55.53M |
| Sales Growth (year/est) | -1.68% | 1.70% | 5.67% | 17.33% |
Earnings History
| CURRENCY IN USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.43 | -0.35 | -0.35 | -0.28 |
| EPS Actual | -0.31 | -0.19 | -0.16 | -0.28 |
| Difference | 0.12 | 0.16 | 0.19 | 0 |
| Surprise % | 28.32% | 45.71% | 53.96% | 1.75% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.24 | -0.24 | -0.9 | -0.72 |
| 7 Days Ago | -0.29 | -0.25 | -0.93 | -0.86 |
| 30 Days Ago | -0.29 | -0.25 | -0.93 | -0.86 |
| 60 Days Ago | -0.29 | -0.25 | -0.93 | -0.86 |
| 90 Days Ago | -0.29 | -0.25 | -0.93 | -0.86 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | 1 | 3 | 4 |
| Up Last 30 Days | 1 | 2 | 4 | 3 |
| Down Last 7 Days | 1 | -- | 1 | -- |
| Down Last 30 Days | 1 | 1 | -- | 1 |
Growth Estimates
| CURRENCY IN USD | XGN | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 21.77% | -- | -- | 5.00% |
| Next Qtr. | -26.32% | -- | -- | 12.00% |
| Current Year | 32.46% | -- | -- | 2.10% |
| Next Year | 20.44% | -- | -- | 12.20% |
Upgrades & Downgrades
| Maintains | Cantor Fitzgerald: Overweight to Overweight | 5/14/2024 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 9/26/2023 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 8/22/2023 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 5/16/2023 |
| Maintains | BTIG: Buy | 3/22/2023 |
| Maintains | BTIG: Buy | 11/17/2022 |
Related Tickers
IDXG Interpace Biosciences, Inc.
2.8500
-7.41%
PRE Prenetics Global Limited
4.5000
-5.26%
VCYT Veracyte, Inc.
35.94
-2.97%
MDXH MDxHealth SA
1.6400
-6.29%
IBX.AX Imagion Biosystems Limited
0.0420
-12.50%
NEOG Neogen Corporation
14.60
-0.27%
STIM Neuronetics, Inc.
0.7100
-10.13%
BDSX Biodesix, Inc.
1.3450
-3.93%
NOTV Inotiv, Inc.
2.6800
-1.83%
ENZ Enzo Biochem, Inc.
1.0400
0.00%